These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


695 related items for PubMed ID: 18050188

  • 1. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF.
    Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188
    [Abstract] [Full Text] [Related]

  • 2. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J, Handwerger B.
    Rheumatology (Oxford); 2004 Dec 15; 43(12):1555-60. PubMed ID: 15342927
    [Abstract] [Full Text] [Related]

  • 3. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
    Arthritis Rheum; 2004 Mar 15; 50(3):858-65. PubMed ID: 15022328
    [Abstract] [Full Text] [Related]

  • 4. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V, Tomietto P, Venturini P, D'Agostini S, Ferraccioli G.
    Reumatismo; 2006 Mar 15; 58(1):50-8. PubMed ID: 16639488
    [Abstract] [Full Text] [Related]

  • 5. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY, Holliday SL, Williams P, Brey RL.
    Neurology; 2005 Jan 25; 64(2):297-303. PubMed ID: 15668428
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
    Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E.
    Arthritis Rheum; 1998 Jan 25; 41(1):41-7. PubMed ID: 9433868
    [Abstract] [Full Text] [Related]

  • 7. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
    Appenzeller S, Cendes F, Costallat LT.
    Arthritis Rheum; 2009 May 15; 61(5):680-7. PubMed ID: 19405004
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr 15; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 9. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L.
    Arthritis Rheum; 2008 Nov 15; 59(11):1639-46. PubMed ID: 18975359
    [Abstract] [Full Text] [Related]

  • 10. Cognitive dysfunction in systemic lupus erythematosus.
    Emori A, Matsushima E, Aihara O, Ohta K, Koike R, Miyasaka N, Kato M.
    Psychiatry Clin Neurosci; 2005 Oct 15; 59(5):584-9. PubMed ID: 16194262
    [Abstract] [Full Text] [Related]

  • 11. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S, Pereira DA, Costallat LT.
    Lupus; 2008 Nov 15; 17(11):1023-8. PubMed ID: 18852227
    [Abstract] [Full Text] [Related]

  • 12. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
    Ainiala H, Dastidar P, Loukkola J, Lehtimäki T, Korpela M, Peltola J, Hietaharju A.
    Scand J Rheumatol; 2005 Nov 15; 34(5):376-82. PubMed ID: 16234185
    [Abstract] [Full Text] [Related]

  • 13. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ, Ravdin LD, Lockshin MD.
    Arthritis Rheum; 2006 Aug 15; 54(8):2515-22. PubMed ID: 16868972
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
    Nery FG, Borba EF, Viana VS, Hatch JP, Soares JC, Bonfá E, Neto FL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):695-700. PubMed ID: 18077068
    [Abstract] [Full Text] [Related]

  • 15. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
    Appenzeller S, Rondina JM, Li LM, Costallat LT, Cendes F.
    Arthritis Rheum; 2005 Sep 01; 52(9):2783-9. PubMed ID: 16142703
    [Abstract] [Full Text] [Related]

  • 16. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ, Vinagre F, Nero P, Barcelos F, Barcelos A, Rodrigues AM, de Matos AA, Silva C, Miranda L, Capela S, Marques A, Branco J, da Silva JC.
    Ann N Y Acad Sci; 2009 Sep 01; 1173():822-8. PubMed ID: 19758234
    [Abstract] [Full Text] [Related]

  • 17. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus.
    Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA.
    J Int Neuropsychol Soc; 1997 Jul 01; 3(4):377-86. PubMed ID: 9260447
    [Abstract] [Full Text] [Related]

  • 18. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
    Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, Maldonado-Velázquez MR, Beristain-Manterola R, Maeno N, Takei S, Falcini F, Lepore L, Spencer CH, Pratsidou-Gertsi P, Martini A, Ravelli A.
    Arthritis Rheum; 2004 Jun 15; 51(3):458-64. PubMed ID: 15188334
    [Abstract] [Full Text] [Related]

  • 19. Cognitive function in a systemic lupus erythematosus inception cohort.
    Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL.
    J Rheumatol; 2008 Sep 15; 35(9):1776-81. PubMed ID: 18634154
    [Abstract] [Full Text] [Related]

  • 20. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM.
    Arch Intern Med; 2006 Nov 13; 166(20):2278-84. PubMed ID: 17101948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.